Suppr超能文献

奴卡菌病:最新进展和临床概述。

Nocardiosis: updates and clinical overview.

机构信息

Division of Infectious Diseases, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Mayo Clin Proc. 2012 Apr;87(4):403-7. doi: 10.1016/j.mayocp.2011.11.016.

Abstract

Nocardia, a gram-positive bacillus with the microscopic appearance of branching hyphae, can produce considerable disease in the appropriate host. The taxonomy of Nocardia continues to evolve; more than 50 species have been described. Early recognition and effective therapy are imperative to achieve successful outcomes. Although nocardiosis typically occurs in patients with cell-mediated immunosuppressive conditions, infection may occasionally develop in immunocompetent patients as well. This review addresses the microbiology of Nocardia, risk factors for infection, clinical presentations, and management strategies.

摘要

诺卡菌,一种革兰阳性杆菌,具有分支状菌丝的微观外观,在合适的宿主中可引起严重疾病。诺卡菌的分类学仍在不断发展;已经描述了超过 50 种。早期识别和有效治疗对于获得成功的结果至关重要。尽管诺卡菌病通常发生在细胞介导的免疫抑制患者中,但免疫功能正常的患者也可能偶尔发生感染。本文综述了诺卡菌的微生物学、感染的危险因素、临床表现和治疗策略。

相似文献

1
Nocardiosis: updates and clinical overview.奴卡菌病:最新进展和临床概述。
Mayo Clin Proc. 2012 Apr;87(4):403-7. doi: 10.1016/j.mayocp.2011.11.016.
2
First Case of Causing Primary Cutaneous Nocardiosis in an Immunocompetent Patient.首例免疫功能正常患者原发性皮肤诺卡菌病。
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620938228. doi: 10.1177/2324709620938228.

引用本文的文献

10
Nocardiosis: A case series and literature review.诺卡菌病:病例系列报道及文献综述
Biomedica. 2025 May 30;45(2):197-214. doi: 10.7705/biomedica.7486.

本文引用的文献

4
Pulmonary nocardiosis: risk factors and outcomes.肺诺卡菌病:危险因素与预后
Respirology. 2007 May;12(3):394-400. doi: 10.1111/j.1440-1843.2007.01078.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验